Companies
- Companies
- Company details
APR Applied Pharma Research S.A.
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare.
The company in detail
Profile
APR Applied Pharma Research s.a. is an independent, international and integrated Healthcare Company headquartered in Switzerland with a subsidiary in Charlotte (NC, USA) and focused on three major areas: Delivering, Funding and Supporting Innovation in Healthcare.
In particular, APR develops and licenses innovative, value added and patented healthcare products and proprietary drug delivery systems primarily in the oral and topical fields;
APR also invests in companies or early stage innovative projects and provides a balanced mix of equity funding and/or financing together with APR’s development, scientific, technical, marketing, licensing and management skills and know how;
finally, APR supports biotech and pharmaceutical companies in the development of new pharmaceutical projects by providing on a contract basis added value, consultancy and R&D services under contract using a General Contractor approach.
APR has entered into licensing and partnership agreements with pharmaceutical companies in over 100 countries worldwide with international sales on a worldwide basis.
Partnering strategy/interests
APR is interested to evaluate any partnering opportunity with drug discovery as well as drug delivery companies focused in oral and topical products and interested to join forces and boost product development of new innovative drugs.
APR is also interested to evaluate in-licensing opportunities of promising early stage drug candidates in the oral, topical and transdermal areas.
Out-licensing
In-licensing
Services
Wide and well established experience in the development of dermo-cosmetic formulations such as gels, creams, vegetable masks, lotions, cleansers, etc.
moreWide and well established experience in the development of oral fast release formulations such as tablets, granulates, liquids, etc. using also taste masking technology when required.
moreWide and well established experience in the development of oral multilayered controlled release formulations in tablets form.
moreWide and well established experience in the development of topical formulations such as gels, creams, patches, etc.
moreR&D
Partnerships
Deals
Press Releases
FOSTER CITY, CA and BALERNA, SWITZERLAND, July 27, 2009 More
Related Reports
Contact details
Head office
Company figures
Annual Turnover: 10'000'000 (2009)
Number of employees: 31
Related categories
- Industry sector
- Drug delivery / Oral solid
- Drug delivery / Topical
- Drug delivery / Oral solid / Tablet
- Drug delivery / Oral solid / Sustained Release
- Drug delivery / Oral liquid / Suspension
- Drug delivery / Oral liquid / Syrup
- Drug delivery / Systemic / Transdermal system
- Pharmaceutical / Prescription
- Pharmaceutical / OTC/Non-Prescription
- Pharmaceutical / Generics
- Pharmaceutical / Personal Care
- Service / Clinical research
- Service / Product development
- Service / Regulatory affairs
- Therapeutic target
- Cardiovascular
- Central Nervous System
- Central Nervous System / Pain / Pain management general
- Central Nervous System / Pain / Pain, acute
- Central Nervous System / Pain / Pain, back upper/lower
- Central Nervous System / Pain / Pain, cancer
- Central Nervous System / Pain / Pain, inflammatory
- Dermatological
- Gastrointestinal
- Infectious diseases
- Infectious diseases / Diseases / Infection, viral (other)
- Infectious diseases / Bacteria or virus / Herpes simplex virus
- Infectious diseases / Diseases / HIV
- Metabolism
- Musculoskeletal
- Musculoskeletal / Back pain
- Musculoskeletal / Skeletal / Arthritis (non-specific)
- Musculoskeletal / Skeletal / Rheumatoid arthritis
- Musculoskeletal / Skeletal / Rheumatic disorders (other)
- Oncology
- Oncology / Cancer (other)
- Respiratory
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us